We are live on ! Find out more
ALBO

Albireo Pharma Inc
ALBO

Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

1 hedge funds and large institutions have $44 invested in Albireo Pharma Inc in 2025 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

94% less capital invested

Capital invested by funds: $744 → $44 (-$700)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
HNB
1
Huntington National Bank
Ohio
$44 – – –

ALBO Hedge Fund Activity: Q4 2025 in Review

1 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q4 2025, worth a combined $44 — down 94% from $744 a quarter earlier.

Fund positioning in ALBO was balanced in Q4 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Albireo Pharma Inc (ALBO) as of Q4 2025, unchanged from Q3 2025.
  • Funds reported $44 of Albireo Pharma Inc stock for Q4 2025, down 94% quarter-over-quarter.
  • 0 funds opened new Albireo Pharma Inc positions in Q4 2025 and 0 closed out.

Based on aggregated 13F filings for Q4 2025.